Reapplix announced that it has received US FDA 510(k) clearance for its 3C Patch System. LeucoPatch is a triple layer...
FDA has accepted for review the resubmitted new drug application for the transdermal sumatriptan migraine patch NP101 fom NuPathe. The...
Agile Therapeutics has made a new drug application for its once-weekly, low-dose contraceptive patch, AG200-15,(ethinyl estradiol plus levonorgestrel) and the...
The FDA has expanded the approved indication for Exelon Patch (rivastigmine transdermal system), from Novartis, to include the treatment of...
NuPathe Inc.has announced that the FDA has approved Zecuity (sumatriptan iontophoretic transdermal system) for the acute treatment of Migraine with...
Bayer HealthCare has submitted an application for marketing authorization in the European Union for a new transparent low dose contraceptive...
Alvogen has launched the first generic equivalent of Exelon patch (rivastigmine transdermal system) in the United States. The product will...
The FDA has approved an additional indication for Ethicon's Evarrest (fibrin sealant patch), as an adjunct to hemostasis for control...
The FDA is investigating the risk of serious burns and potential permanent scarring with the use of Zecuity (sumatriptan iontophoretic...
Studies of IQP-0410, from ImQuest Biosciences, a promising HIV therapeutic, demonstrate that it can be applied to the skin of...